Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

124 * ! Mon, 7/31/2017, 8:30 AM - 10:20 AM CC-319
Special Topics in Clinical Trial Design and Analysis — Contributed Papers
Biopharmaceutical Section
Chair(s): Isaac Nuamah, Janssen R & D
8:35 AM Selection Bias in Studies with Unequal Allocation Olga M Kuznetsova, Merck & Co., Inc.
8:50 AM Phase II Trials and the Use of Registry Controls Ruta Brazauskas, Institute for Health & Society-Medical College of Wisconsin ; Brent Logan, Institute for Health & Society-Medical College of Wisconsin ; Raphael Fraser, Institute for Health & Society-Medical College of Wisconsin
9:05 AM Simulation-Based Evaluation of P-Value Quality in Phase 3 Clinical Trials Jihao Zhou, Allergan, Inc. ; Ray Zhu, Allergan, Inc. ; Brandon Wales, University of California at Riverside ; Thomas Lin, University of California at Irvine
9:20 AM Inverse Probability of Treatment Weighted Estimator for Exposure Adjusted Incidence Rate Ratio for Rare Adverse Event in Pooled Studies Controlling for Confounding by Study Hui Wang, Astrazeneca ; Sudipta Bhattacharya, AstraZeneca
9:35 AM Flexible Hypothesis Testing Method for Clinical Trials Using Composite Endpoint Jin Xu, Merck ; David Li, Pfizer
9:50 AM Optimal Design of Experiments with the Observation Censoring Driven by Random Enrollment of Subjects Xiaoqiang Xue ; Valerii Fedorov, ICONplc
10:05 AM Floor Discussion
Copyright © American Statistical Association